BioNTech SE
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
BNTX Key Statistics
Stock Snapshot
As of today, BioNTech SE(BNTX) shares are valued at $101.50. The company's market cap stands at 24.39B, with a P/E ratio of -38.97.
On 2025-11-19, BioNTech SE(BNTX) stock traded between a low of $101.18 and a high of $103.89. Shares are currently priced at $101.50, which is +0.3% above the low and -2.3% below the high.
BioNTech SE(BNTX) shares are trading with a volume of 594.67K, against a daily average of 974.75K.
In the last year, BioNTech SE(BNTX) shares hit a 52-week high of $129.27 and a 52-week low of $81.20.
In the last year, BioNTech SE(BNTX) shares hit a 52-week high of $129.27 and a 52-week low of $81.20.
BNTX News
Pfizer (NYSE:PFE) is reportedly offloading its remaining stake in Covid-19 vaccine partner BioNTech SE (NASDAQ:BNTX) . BNTX is among today's weakest performers...
